Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas
Keywords: Wnt pathway; β-Catenin; Wnt inhibitory factor-1; Estrogen receptor-α; Fulvestrant; Prolactinoma